banner
EGFR-HER2 inhibitor BIBX 1382, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ1057

EGFR-HER2 inhibitor BIBX 1382, Purity ≥98%

Synonym: Falnidamol; 196612-93-8; BIBX 1382; BIBX1382; BIBX-1382; N8-(3-Chloro-4-fluorophenyl)-N2-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine; EGFR-HER2 inhibitor

  • MDL: MFCD09838900
  • CAS Number: 196612-93-8
  • Compound CID: 6918508
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BIBX 1382 is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR and ErbB2.
Molecular Weight
460.8
Molecular Formula
C18H19ClFN7.2HCl
Targets
EGFR: 3 nM; ErbB2: 3.4 μM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BIBX 1382 can be used to inhibit EGFR tyrosine kinase for research into cancer therapy.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0